Abiopharma

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

EDAP Receives HIFU Reimbursement for Prostate Cancer in France

New Form 8-K - ANI PHARMACEUTICALS INC Filed: 2025-09-08 AccNo: 0001023024-25-000089 Size: 5 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Pfizer Inc. - Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula

Lillys Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) BTK inhibitor, significantly improved progression-free survival in patients with treatment-naïveCLL/SLL

Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula

New Form 8-K - Vicarious Surgical Inc. Filed: 2025-09-08 AccNo: 0001213900-25-085274 Size: 11 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Regeneron Advances Allergy Pipeline with Two Positive Phase 3 Trials Evaluating First-in-Class Antibody-Blockers of Cat and Birch Allergies

Elanco Animal Health Inc. - Elanco Innovation Builds Momentum, Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Reaches Blockbuster Status

Elanco Innovation Builds Momentum, Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Reaches Blockbuster Status

New Form 6-K - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-09-08 AccNo: 0001395064-25-000130 Size: 15 MB

New Form SCHEDULE 13G - APPLIED DNA SCIENCES INC Filed: 2025-09-08 AccNo: 0001213900-25-085271 Size: 18 KB

New Form 8-K - MAIA Biotechnology, Inc. Filed: 2025-09-08 AccNo: 0001493152-25-012769 Size: 18 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - IDEAYA Biosciences, Inc. Filed: 2025-09-08 AccNo: 0001193125-25-197605 Size: 180 KB Item 8.01: Other Events

New Form 6-K - Burning Rock Biotech Ltd Filed: 2025-09-08 AccNo: 0001193125-25-197601 Size: 225 KB